Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Clinical trial NCT01095120 · UNKNOWN

Trial details

NCT number: NCT01095120
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Stomach Adenocarcinoma of Esophagogastric Junction

Start date: 2010-03-01
Primary completion: 2012-09-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.